Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Pancreatic Neoplasms × pegfilgrastim × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Sarcoma 3 Lymphoma 3 Breast Neoplasms 3 Rhabdomyosarcoma 2 Lymphoma, Large B-Cell, Diffuse 2 Lung Neoplasms 2 Carcinoma 2 Teratoma 1 Sarcoma, Synovial 1 Recurrent Uterine Corpus Carcinoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neutropenia 1 Neurofibrosarcoma 1 Malignant mesenchymal tumor 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Follicular 1 Liposarcoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Leiomyosarcoma 1 Inflammatory Breast Neoplasms 1 Hodgkin Disease 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Fibrosarcoma 1 Fallopian Tube Neoplasms 1 Endometrial Adenosquamous Carcinoma 1 Endometrial Adenocarcinoma 1 Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Gemcitabine 15 Fluorouracil 8 Leucovorin 5 Capecitabine 5 Irinotecan 4 Cisplatin 4 Albumin-Bound Paclitaxel 4 130-nm albumin-bound paclitaxel 4 Taxes 3 Radiotherapy, Conformal 3 Radiotherapy 3 Docetaxel 3 irinotecan sucrosofate 2 dehydroftorafur 2 Specimen Handling 2 Radiosurgery 2 Pancreaticoduodenectomy 2 Cetuximab 2 trametinib 1 saracatinib 1 pegfilgrastim 1 lanreotide 1 ganitumab 1 durvalumab 1 conatumumab 1 beta-D-glucosylisophosphoramide mustard 1 Watchful Waiting 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Saline Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06094140 2024-12-03

NEO-IMPACT

Australasian Gastro-Intestinal Trials Group

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡